Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Trans-Sahara Investment Corporation is a private equity and direct investment firm focused on originating, developing, and actively managing investments in West Africa, particularly Nigeria. Publicly available sources describe it as an investor across diversified sectors including financial services, telecommunications, consumer, agriculture, energy, logistics, real estate, education, retail, and healthcare. However, it does not appear to be a biotech, pharmaceutical, life sciences, or healthcare operating company. Multiple business databases indicate that the firm is inactive or closed. As a result, there is no drug pipeline, platform technology, or therapeutic development program associated with the entity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Trans-Sahara Investment Corporation.